The Pharma Data

JUNE 6, 2025

As pharma companies grapple with mounting pressure from regulators, payers, and evolving market dynamics, the CSO model offers a compelling alternative to traditional, fully in-house sales forces. Biosimilars and Generics : Where cost competition necessitates strategic brand differentiation and efficient coverage.

Pharmaceutical Companies 40

Pharmaceutical Companies Compliance Pharmaceuticals International 40

Drug Target Review

MARCH 13, 2025

Surveys (eg, 2024 State of Tech in Biopharma Report ) predict a doubling of R&D data year-over-year in 2025, highlighting the continued growth of available data. Techbio companies have initiated this approach. Now even non-AI native big pharma companies take a similar view on using clinical genomics with integrated multimodality.

Drug Development 59

Drug Development Science Clinical Trials Drugs 59

BioPharma Drive: Drug Pricing

JUNE 12, 2025

Deep Dive Library Events Press Releases Topics Sign up Search Sign up Search Pharma Biotech FDA Clinical Trials Deals Drug Pricing Gene Therapy An article from Pharma’s wins and losses in the budget bill Key pharma reforms are up in the air as Republicans battle over their mammoth legislation that includes significant healthcare spending cuts.

Small Molecule 130

Small Molecule Packaging Therapies Pharmacy 130